← All organizations
Highest phase reached
Phase 4
First clinical trial
May 26, 2000Last known activity
Dec 5, 2018
Timeline
1950s
- Jan 1, 1950
Muscular Dystrophy Association— Founded
Drugs by trial phase (14 distinct, 13 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Indications
Studied for
- Amyotrophic Lateral Sclerosis
- Charcot-Marie-Tooth Disease
- Hereditary Sensory and Motor Neuropathy
- Motor Neuron Disease
- Muscle Weakness
- Muscular Dystrophies
- Muscular Dystrophies, Limb-Girdle
- Muscular Dystrophy, Duchenne
- Myasthenia Gravis
- Myotonic Dystrophy
- Nerve Compression Syndromes
- Sarcoglycanopathies
- Sclerosis
- Tooth Diseases
Recent trials (13)
- NCT03777319CollaboratorPhase 1Dec 5, 2018
- NCT03639701CollaboratorPhase 1/Phase 2May 16, 2017
- NCT01555580Lead sponsorEarly Phase 1Apr 1, 2012
- NCT01070511CollaboratorPhase 4Jan 1, 2010
- NCT01041222CollaboratorPhase 1Jan 1, 2010
- NCT01083667CollaboratorPhase 1/Phase 2Nov 1, 2009
- NCT00790582CollaboratorPhase 2May 1, 2008
- NCT00494195CollaboratorPhase 1Mar 1, 2008
- NCT00577577CollaboratorPhase 2Dec 1, 2007
- NCT00484510CollaboratorPhase 2/Phase 3Apr 1, 2007
- NCT00264888CollaboratorPhase 2Dec 1, 2005
- NCT00107770CollaboratorPhase 1/Phase 2Apr 1, 2005
- NCT00005674CollaboratorPhase 2May 26, 2000
Details
- Founded
- New York, NY, US Jan 1, 1950
- Last known activity
- Dec 5, 2018